Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

R. Abu‐Rustum, Nadeem; M. Yashar, Catheryn; C. Arend, Rebecca; L. Barber, Emma; Bradley, Kristin; Brooks, Rebecca; M. Campos, Susana; Chino, Junzo; Sook Chon, Hye; A. Crispens, Marta; Damast, Shari; M. Fisher, Christine; J. Frederick, Peter; K. Gaffney, David; Gaillard, Stéphanie; Giuntoli, Robert; Glaser, Scott; A. Holmes, Jordan; E. Howitt, Brooke; Kendra, Kari; Lea, Jayanthi; K. Lee, Nita; Mantia-Smaldone, Gina; Mariani, Andrea; G. Mutch, David; Nagel, Christa; Nekhlyudov, Larissa; Podoll, Mirna; J. Rodabaugh, Kerry; Salani, Ritu; O. Schorge, John; Siedel, Jean; Sisodia, Rachel; T. Soliman, Pamela; Ueda, Stefanie; R. Urban, Renata; L. Wethington, Stephanie; Wyse, Emily; Zanotti, Kristine; R. McMillian, Nicole; Espinosa, Sara

doi:10.6004/jnccn.2024.0013

Public

Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Mar 1, 2024

Authors:

Nadeem R. Abu‐Rustum

Catheryn M. Yashar

Rebecca C. Arend

Abstract

Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of gynecologic malignancies. Known risk factors for vulvar cancer include increasing age, infection with human papillomavirus, ...

Subject

Medicine

Vulvar cancer

Vulva

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!